Navigation Links
Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer
Date:2/1/2012

mate," "expect," "intend," "plan," "will" and other similar expressions identify forward-looking statements, although not all forward-looking statements contain these identifying words. In particular, any statements regarding the safety and efficacy of KRYSTEXXA®, status of our KRYSTEXXA marketing efforts and additional plans related thereto, market demand and reimbursement for KRYSTEXXA, our view of the refractory chronic gout (RCG) market size, and our market expansion plans including our MAA filing before the EMA are forward-looking statements. These forward-looking statements involve substantial risks and uncertainties and are based on our assessment and interpretation of the currently available data and information, current expectations, assumptions, estimates and projections about our business and the biopharmaceutical and specialty pharmaceutical industries in which we operate. Important factors that may affect our ability to achieve the matters addressed in these forward-looking statements include, but are not limited to, our ability to commercialize KRYSTEXXA; the risk that the market for KRYSTEXXA is smaller than we have anticipated; our ability to retain the personnel; our reliance on third parties to manufacture KRYSTEXXA; competition from existing therapies and therapies that are currently under development, including therapies that are significantly less expensive than KRYSTEXXA; our ability to gain market acceptance for KRYSTEXXA among physicians, patients, health care payers and others in the medical community; whether we are able to obtain financing, if needed; economic, political and other risks associated with foreign operations; risks of maintaining protection for our intellectual property; risks of an adverse determination in intellectual property litigation; and risks associated with stringent government regulation of the biopharmaceutical industry and other important factors set forth more fully in our reports filed with the Se
'/>"/>
SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... 12, 2014 Mindray Medical International Limited ("Mindray", ... and marketer of medical devices worldwide, today announced shareholder ... held in Hong Kong on ... shareholders voted to re-elect incumbent directors Li Xiting and ... shareholders did not re-elect Peter Wan as ...
(Date:12/13/2014)... , Dec. 12, 2014  Novo Nordisk, a world leader ... announced a multi-year extension of their partnership, that will renew ... Novo Nordisk Chip Ganassi Racing entry, driven by Charlie ... Kimball, 29, from Camarillo, California , is ... history of INDYCAR to win a race at the most ...
(Date:12/13/2014)... Research and Markets ( http://www.researchandmarkets.com/research/5ft7zn/china_chemical ... "China Chemical Pharmaceutical Industry Report, 2013-2016"  report to ... Chemical pharmaceutical ... pharmaceutical ingredient (API), and the gross margin of ... that of the API over the same period. ...
Breaking Medicine Technology:Mindray Announced Shareholder Resolutions Post 2014 Annual General Meeting 2Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 2Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 3Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 4Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 5Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 6Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 7China Chemical Pharmaceutical Industry Report, 2013-2016 2China Chemical Pharmaceutical Industry Report, 2013-2016 3
... SEATTLE, April 27, 2011 Cell Therapeutics, Inc. ("CTI" ... accomplishments and financial results for the first quarter ended ... we raised $50 million through two financings, advanced pixantrone ... license from Chroma Therapeutics Ltd. ("Chroma") to co-develop and ...
... The Premier healthcare alliance, a network ... healthcare sites working together to achieve high quality, cost-effective ... leading provider of FDA-approved Superficial Radiotherapy committed to providing ... sufferers, a group purchasing agreement for the SRT-100™. Sensus ...
Cached Medicine Technology:Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 2Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 3Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 4Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 5Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 6Sensus Healthcare Awarded Sole Contract for Superficial Radiotherapy 2Sensus Healthcare Awarded Sole Contract for Superficial Radiotherapy 3
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 ... and work commitment is a big reason why, new research ... Dr. Mathias Basner, an assistant professor of sleep and chronobiology ... Medicine. A time-use survey of nearly 125,000 Americans, ages ... activity exchanged for sleep. Short sleepers -- those who slept ...
(Date:12/15/2014)... 2014 Main Street Dental Team ( ... in on a new study providing evidence on the ... hygiene of children. , Sufficient enough evidence already exists ... pop or juice drinks, with the onset of tooth ... whether drinks listed as 100% fruit juice, meaning it ...
(Date:12/15/2014)... December 15, 2014 Health Dialog, ... announced today that it has received Patient Oriented ... (NCQA) for its Disease Management (DM) Programs for ... (COPD), coronary heart disease and diabetes. This marks ... for Health Dialog’s Disease Management (DM) Programs, reaffirming ...
(Date:12/15/2014)... 2014 Kathy McAfee, America's Marketing Motivator, ... Awards in the category of Best Blog 2014. McAfee ... her weekly career blog Networking Ahead which ... professionals elevate their talent and influence through better networking, ... her book Networking Ahead for Business, has been motivating ...
(Date:12/15/2014)... Bacteroides is becoming the indicator of choice for ... prevalent than coliforms, it cannot reproduce in the presence of ... Key Benefits of the new Bacteroides Sewage Screen:, ... Eliminates false positives from coliforms naturally occurring in the environment ... Maintain the same sampling method with results as quick ...
Breaking Medicine News(10 mins):Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2
... Reinberg HealthDay Reporter , WEDNESDAY, June 22 (HealthDay ... standard drugs, is highly effective at treating hepatitis C, a ... The drug works not only in patients just starting treatment, ... The hepatitis C virus can lurk in the body ...
... Its well known that drunk driving can have fatal consequences, but ... thats a danger on ,the road. , It might make sense ... to crashes. But few studies have actually looked ,specifically at the ... is an increasing push to pass drugged driving laws nationally.,In the ...
... 2011) -- The drug telaprevir (Incivek) provides a dramatic improvement ... C infection, says an international team of investigators led by ... Their study, published in today,s edition of the ... the agent for patient use by the U.S. Food and ...
... HealthDay Reporter , WEDNESDAY, June 22 (HealthDay News) ... far from far-reaching, as a new analysis points to the ... red meat as a major cause of weight gain in ... factors such as television watching, exercise and sleep were also ...
... 22 (HealthDay News) -- A new test that uses a ... range could prove useful in solving crimes and improving patient ... test focuses on a process called methylation, a chemical modification ... DNA. "While genes partly shape how our body ages, ...
... University Medical Center (GUMC) have defined, for the first time, ... identify sounds such as speech and discovered that they ... In the June 22 issue of the Journal of ... with the help of 13 human volunteers who spent time ...
Cached Medicine News:Health News:New Drug Effectively Treats Hepatitis C 2Health News:New Drug Effectively Treats Hepatitis C 3Health News:New Drug Effectively Treats Hepatitis C 4Health News:Drug use tied to fatal car crashes 2Health News:Drug use tied to fatal car crashes 3Health News:NEJM study: New drug represents breakthrough in treatment of hepatitis C 2Health News:NEJM study: New drug represents breakthrough in treatment of hepatitis C 3Health News:Chips, Fries, Soda Most to Blame for Long-Term Weight Gain 2Health News:Chips, Fries, Soda Most to Blame for Long-Term Weight Gain 3Health News:Simple Saliva Test Detects Your 'Real' Age 2Health News:Researchers identify components of speech recognition pathway in humans 2Health News:Researchers identify components of speech recognition pathway in humans 3
Large solid mallet with patented Ortho-Grip® silicone rubber handle....
Straight chisel for scoring, cutting, scraping, cleaning and sculpting bone....
Custom-made chisels....
Lewin Bone Forceps, serrated and slightly curved. To hold, stabilize, rotate, reduce and,compress bone....
Medicine Products: